Kyverna Therapeutics is positioned to pioneer the autoimmune CAR T space. Click here to see why KYTX stock is a Buy.

Marking the fifth consecutive year of Noah's semiannual CIO reports and the 12th edition in the series, this report formally introduces the 'Noah World Model' into its CIO research framework for the ...

Business transformation is AI’s great promise, but according to Deloitte, deploying new tools is the easy part. To define and ...